Liver & Hepatitis

Ankrah NA, Rikimaru T, Ekuban FA, Addae MM. Decreased cysteine and glutathione levels: possible determinants of liver toxicity in Ghanian subjects. Journal of Int Medical Research 22(3): 171-6, 1994 Medline

Barbaro G, Di Lorenzo G, Soldini M, et al. Hepatic glutathione deficiency in chronic hepatitis C: quantitative evaluation in patients who are HIV positive and HIV negative and correlations with plasmatic and lymphocytic concentrations and with the activity of the liver disease. Amer Journal of Gastroenterology 91: 2569-2573, 1996 Medline

Beloqui O, Prieto J, Suarez M, Gil B, Qian CH, Garcia N, Civeira MP. N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study. Journal of Interferon Research 13:279-282, 1993 Medline

Bresci G, Piccinocchi M, Banti S. The use of reduced glutathione in alcoholic hepatopathy. Minerva Medicine 82: 753-755, 1991 Medline

Dentico P, Volpe A, Buongiorno R, et al. Glutathione in the treatment of chronic fatty liver diseases. Recent Prog Med 86:290-293, 1995 Medline

Farinati F, Cardin R, De Maria N, et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. Journal of Hepatology 22: 449-456, 1995 Medline

Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. New England Journal of Medicine 324: 1852-1857, 1991 Medline

Jewell SA, Di Monte D, Gentile A, Guglielmi A, Altomare E, Albano O. Decreased hepatic glutathione in chronic alcoholic patients. Journal of Hepatology 3:1-6, 1986 Medline

Lieber CS. Susceptibility to alcohol-related liver injury. Alcohol 2(supl): 315-326, 1994 Medline

Loguercio C, Taranto D, Vitale LM, Beneduce F, Del Vecchio Blanco C. Effect of liver cirrhosis on the glutathione concentration in the plasma, erythrocytes, and gastric mucosa of man. Free Radical Biology Medicine 20: 483-488, 1996 Medline

Mulder TP, Janssens AR, De Bruin WC, et al. Plasma glutathione S-transferase alpha 1-1 levels in patients with chronic liver disorders. Clin Chim Acta 258:69-77, 1997 Medline

Nardi EA, Devito R, Ceccanti M. High-dose glutathione in the therapy of alcoholic hepatopathy. Clinical Ter 136:47-51, 1991 Medline

Pressman, AH. The GSH Phenomenon. New York NY, St. Martin’s Press, First ed., 1997

Savolainen VT, Pjarinen J, Perola M, Penttila A, Karhunen PJ. Glutathione S-transferase GST M1 “null” genotype and the risk of alcoholic liver disease. Alcohol Clinical Experimental Research 20: 1340-1345, 1996 Medline

Proceedings of the 16th International Congress of Nutrition. Montreal, PR514, 1997

Watanabe A, Higuchi K, Okada Y, Shimizu Y, Kondo Y, Kohri H. Nutritional therapy of chronic hepatitis by whey protein (non-heated). Medline

Watanabe A, Higuchi K, Yasumura Y, Shimizu Y, Kondo Y, Kohri H. Nutritional modulation of glutathione level and cellular immunity in chronic hepatitis B and C. Hepatology 24:pt2: 597A: 1883, 1996

Weiss L, Hildt E, Hofschneider PH. Anti-hepatitis B virus activity of N-acetyl L-cysteine (NAC): New aspects of a well-established drug. Antiviral Research 32: 43-53, 1996 Medline